 role etoposid manag lymphoma hodgkin diseas etoposid deriv epipodophyllotoxin import new drug manag malign lymphoma past decad number specif protocol use agent manag malign lymphoma time primari treatment relaps broad activ etoposid sever histolog subtyp malign lymphoma hodgkin diseas potenti optim dose schedul etoposid single-ag activ rival drug agent doxorubicin protein synthesi topoisomeras II inhibitor potenti non-cross-resist cytotox brief comment single-ag activ etoposid report integr etoposid multiag protocol primari treatment malign lymphoma hodgkin diseas specif find protocol prednison methotrex doxorubicin cyclophosphamid etoposide-cytarabin bleomycin vincristin methotrex pro-mace-cytabom US nation cancer institut nci doxorubicin cyclophosphamid vincristin prednison bleomycin vacop-b vancouv primari treatment malign lymphoma vinblastin cyclophosphamid doxorubicin bleomycin vincristin prednison vecabop vancouv treatment untreat patient advanc hodgkin diseas